TENANTS

Archive | Resident Company News

BMG LABTECH and InvivoSciences, Inc. Initiate Market Collaboration To Accelerate Drug Discovery in Engineered 3D Tissues

Cary, NC – November 17, 2013. BMG LABTECH, Inc. – the Microplate Reader Company – and InvivoSciences, Inc. – a leader in stem cell tissue engineering providing a novel solution in first-in-class drug discovery – announced today a strategic collaboration to market the time-dependent fluorescent assessment of engineered 3D heart tissues using advanced microplate reader […]

Continue Reading

NCD Technologies Officially Recognized on R&D Magazine’s 100 Awards List for 2013

NCD Technologies, a rising star in nano technologies, is proud to announce that their Nanocrystalline Diamond Pretreatment (NDP) an innovative and unprecedented process for applying diamond coatings to extremely small tooling, has been selected by R&D Magazine’s 100 list for technological excellence. NCD Technologies’ coatings are the result of a state-of-the-art pretreatment process for applying […]

Continue Reading

Stratatech (private) awarded BARDA contract valued up to $47.2 M

For Advanced Development of StrataGraft® Skin Tissue for Thermal Burns Stratatech Corp has been awarded a contract valued at up to $47.2 M by the U.S. Department of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA). The contract is for the advanced clinical and manufacturing development of StrataGraft® skin tissue, its skin […]

Continue Reading

FluGen and UK’s Arecor Receive Funding Award

Arecor Ltd of Cambridge, England received the “green light” and funding to pursue a research project applying Arecor’s innovative Arestat™ formulation technology to a promising flu vaccine, REDEE FLU™, developed by FluGen, Inc., of Madison, WI. The UK’s innovation agency, the Technology Strategy Board, has awarded Arecor a Proof of Concept award through its Smart […]

Continue Reading

Primorigen Biosciences gets grant for stem cell work

Primorigen Biosciences, Madison, has received a $1.2 million Phase 2 Small Business Innovation Research grant from the National Institutes of Health. The funds will speed the company’s work on a new, cost-effective system for producing stem cells and transforming them into specific cell lines, such as blood, liver and neural cells, said chief executive Chuck […]

Continue Reading
Facebook IconYouTube IconTwitter IconVisit Our LinkedIn Profile